Loading clinical trials...
Loading clinical trials...
Progressive Supranuclear Palsy (PSP) is a relentlessly progressive neurodegenerative disorder, clinically characterized by parkinsonism with prominent axial involvement and postural instability, bulba...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nantes University Hospital
NCT05121012 · Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more
NCT03174938 · Dementia, Alzheimer Disease, and more
NCT06162013 · Progressive Supranuclear Palsy, Multiple System Atrophy, and more
Service de Neurologie A, Hôpital Gabriel Montpied-BP
Clermont-Ferrand
Service de Neurologie et Pathologie du mouvement Hôpital Roger Salingro, CHRU de Lille
Lille
Service de Neurologie, CHU Nantes
Nantes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions